About Adragos Pharma
Adragos Pharma is a company based in Munchen (Germany) founded in 2020 by Andreas Raabe was acquired by FSN Capital in August 2021. Adragos Pharma has completed 2 acquisitions, including Baccinex and Lamda.
- Headquarter Munchen, Germany
- Founders Andreas Raabe
-
Sectors
Financial Services
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Baccinex
& 1 more
-
Acquired by
FSN Capital
(Aug 09, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Adragos Pharma
Unlock access to complete
Funding Insights of Adragos Pharma
Detailed funding history for Adragos Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Adragos Pharma
Adragos Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include FSN Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked |
Investor details for Adragos Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Adragos Pharma
Adragos Pharma has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Baccinex and Lamda.
Investment portfolio details for Adragos Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
CDMO specializing in fill and finishing of sterile lyophilized or liquid dosage forms
|
Locked | Locked | 1999 | Locked | |
|
Laboratory focused on generic drugs development and research services
|
Locked | Locked | 1996 | Locked |
Complete acquisition details for Adragos Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Adragos Pharma
Detailed financials for Adragos Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Adragos Pharma Comparisons
Peer comparison for Adragos Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Adragos Pharma
Detailed competitors of Adragos Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Adragos Pharma
Complete news archive for Adragos Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Adragos Pharma
Adragos Pharma was founded in 2020.
Adragos Pharma is headquartered in Munchen, Germany. It is registered at Munchen, Bayern, Germany.
Andreas Raabe is the current CEO of Adragos Pharma. They have also founded this company.
Adragos Pharma private equity fund investing in healthcare sectors through investment industry, private equity funds, and buyout funds. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Adragos Pharma has 1 investor. Key investors include FSN Capital.